Pam remarked, “The value chain of Life Sciences has been extended by service providers, material suppliers, management consultants and technology enablers. They enable the drug development enterprises to commercialize their intellectual property to deliver patient care. I am ready to provide the Council Members a collaborative platform for engagement with a voice to further innovation and advance the global supply chain.”